Fa-ChyiLeeMD

Clinical Trials

• Combination Paclitaxel, Carboplatin and Temozolomide Start of enrollment: 2003 Nov 01

  Completed

  Phase 1

• Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer Start of enrollment: 2005 Apr 01

  Terminated

  Phase 2

• Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma Start of enrollment: 2000 Sep 01

  Completed

  Phase 1, Phase 2

• Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib Start of enrollment: 2005 Nov 01

  Terminated

• INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer Start of enrollment: 2006 Sep 01

  Terminated

• Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review Start of enrollment: 2006 Feb 01

  Terminated

• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08

  Active, not recruiting

  Phase 3

• Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers Start of enrollment: 2008 Nov 01

  Terminated

  Not Applicable

• Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2008 Oct 01

  Completed

  Phase 2

• Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15

  Completed

  Phase 3

• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18

  Completed

  Phase 2

• Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01

  Completed

  Phase 2

• Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers Start of enrollment: 2015 Nov 01

  Withdrawn

  Phase 2

• Join now to see all